Page 111 - 2019秋季手冊內頁-ebook測試

Sci. 2015 Aug;60(8):2454-62.
2. Clinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference center.
Le PH, Lin WR, Kuo CJ, Wu RC, Hsu JT, Su MY, Lin CJ, Chiu CT. Ther Clin Risk Manag. 2017 Dec
15;13:1585-93.
3. The clinical characteristics and manifestations of cytomegalovirus esophagitis.
Wang HW, Kuo CJ, Lin WR, Hsu CM, Ho YP, Lin CJ, Su MY, Chiu CT, Wang CL, Chen KH. Dis Esophagus. 2016 May;29(4):392-9
4. Clinical Characteristics and outcome of fistulizing Crohn's disease: One Single center Experience in Taiwan.
Tony Kuo, Kuo CJ, Lin WR, Chiu CT, Su MY, Lin WP, Lin CJ, Hsu JT, Tsai WS, Wu RC. Adv Dig Med. 2019;1–7.
5. Mesalazine-related lung disease in a patient with ulcerative colitis: A case report.
Huang PH, Kuo CJ, Lin CW, Cheng YM, Hu HC, Lin CY, Su MY, Chiu CT. Medicine (Baltimore). 2018 Nov;97(48):e13242
6. Pancolitis associated with higher mortality risk of cytomegalovirus colitis in patients without inflammatory bowel disease.
Le PH, Kuo CJ, Wu RC, Hsu JT, Su MY, Lin CJ, Chiu CT. Ther Clin Risk Manag. 2018 Aug 20;14:1445-1451
7. Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections. Kuo CJ, Chen CW, Le PH, Hsu JT, Lin CY, Cheng HT, Su MY, Lin CJ, Chiu CT.
Therap Adv Gastroenterol. 2019 Sep 5;12.
112